Serina Therapeutics, Inc. (SER): Nasdaq/NYSE listing notice — NYSE American grants AgeX extension to May 17, 2023 to meet $4M equity minimum for continued listing

Serina Therapeutics, Inc.

NYSE American accepted AgeX's revised compliance plan and extended deadline to May 17, 2023 for meeting $4M stockholders' equity minimum.
If AgeX fails to comply by May 17, 2023 or fails to meet plan milestones, NYSE American will initiate delisting proceedings.
AgeX intends to arrange for quotation on an electronic interdealer system (e.g., OTC) if delisted from NYSE American.
The Exchange will periodically review AgeX's progress against plan milestones during the extension period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Serina Therapeutics, Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

Exchange: nyse american
Notice: extension granted
Deficiency: stockholders equity
Rules: 1003(a)(i), 1003(a)(ii)

Exact text from the filing

November 22, 2022 we received a notification from the staff of the NYSE American (the “Exchange”) indicating that the Exchange has accepted a revised listing compliance plan from AgeX and has granted AgeX an extension of time to regain compliance with the Exchange’s continued listing standards as set forth in Section 1003(a)(i) and (ii) of the Exchange Company Guide by increasing our stockholders equity to not less than $4,000,000. The Exchange staff will periodically review our adherence to the plan milestones. If we are not in compliance with the continued listing standards by May 17, 2023

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-033719

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.